XML 19 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
May 31, 2018
Jun. 01, 2017
Cash flows from operating activities    
Net income $ 9,812 $ 2,721
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation expense and amortization of intangible assets 3,474 2,795
Amortization of debt discount and other costs 78 93
Loss on debt prepayments, repurchases, and conversions 386 62
Stock-based compensation 151 158
Gain on remeasurement of previously-held equity interest in Inotera 0 (71)
Change in operating assets and liabilities    
Receivables (1,177) (1,338)
Inventories (246) 108
Accounts payable and accrued expenses 38 511
Payments attributed to intercompany balances with Inotera 0 (361)
Deferred income taxes, net (216) 80
Other (55) 192
Net cash provided by operating activities 12,245 4,950
Cash flows from investing activities    
Expenditures for property, plant, and equipment (6,628) (3,469)
Purchases of available-for-sale securities (606) (943)
Payments to settle hedging activities (84) (267)
Acquisition of Inotera 0 (2,634)
Proceeds from sales of available-for-sale securities 569 742
Proceeds from maturities of available-for-sale securities 219 115
Proceeds from settlement of hedging activities 151 146
Other 292 51
Net cash provided by (used for) investing activities (6,087) (6,259)
Cash flows from financing activities    
Repayments of debt (6,767) (1,774)
Payments on equipment purchase contracts (170) (261)
Proceeds from issuance of stock 1,636 108
Proceeds from issuance of debt 969 3,136
Other (111) (2)
Net cash provided by (used for) financing activities (4,443) 1,207
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash (4) (15)
Net increase (decrease) in cash, cash equivalents, and restricted cash 1,711 (117)
Cash, cash equivalents, and restricted cash at beginning of period 5,216 4,263
Cash, cash equivalents, and restricted cash at end of period $ 6,927 $ 4,146